MoonLake Immunotherapeutics AG Announces Closing of Business Combination with Helix Acquisition Corp.

MoonLake Immunotherapeutics AG Announces Closing of Business Combination with Helix Acquisition Corp. MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company elevating care with

Related Keywords

Boston ,Massachusetts ,United States ,Switzerland ,Bihua Chen ,Simon Sturge ,Andrew Phillips ,Kristian Reich ,Moonlake Immunotherapeutics ,Oliver Daltrop ,Kara Lassen ,Matthew Cole ,Ramnik Xavier ,Nuala Brennan ,Kostenloser Wertpapierhandel ,Mary Jane Elliott ,Catherine Moukheibir ,Matthias Bodenstedt ,Exchange Commission ,Helix Acquisition Corp ,Clinical Development ,Nasdaq ,Consilium Strategic Communications ,Closingof Business Combination ,Helix Acquisition ,Beginning April ,Nasdaq Stock Market ,Jorge Santos ,Chief Executive Officer ,Chief Scientific Officer ,Chief Financial Officer ,Chief Clinical Development Officer ,Chief Technology Officer ,Spike Loy ,Securities Litigation Reform Act ,Moonlake ,Immunotherapeutics ,Nnounces ,Closing ,Business ,Combination ,Felix ,Cquisition ,Orp ,